Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomised controlled trial

The Lancet Oncology

Volumn 16, Issue 3, 2015, Pages 266-273

  Kunkler, Ian H ^a   Williams, Linda J ^a   Jack, Wilma J L ^b   Cameron, David A ^a   Dixon, J Michael ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGE; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; BREAST CANCER FREE SURVIVAL; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EARLY HORMONE RECEPTOR POSITIVE NODE NEGATIVE BREAST CANCER; FEMALE; FOLLOW UP; GREECE; HUMAN; INTENTION TO TREAT ANALYSIS; LOW RISK PATIENT; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE COX PROPORTIONAL HAZARDS ANALYSIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SERBIA; SURVIVAL TIME; TUMOR RECURRENCE; UNITED KINGDOM; WHOLE BREAST RADIOTHERAPY; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; BREAST NEOPLASMS; CANCER STAGING; CLINICAL TRIAL; EUROPE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AUSTRALIA; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; EUROPE; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84924962663     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)71221-5     Document Type: Article

References (31)

1. Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012, 13:e148-e160.
2. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years or older with early breast cancer. N Engl J Med 2004, 351:963-970.
3. Blamey RW, Bates T, Chetty U, et al. Radiotherapy or tamoxifen after conserving surgery for breast cancer of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer 2013, 49:2294-2302.
4. Potter R, Gnant M, Kwasny W, et al. Lumpectomy plus tamoxifen with or without wholebreast irradiation in women with favourable breast cancer. Int J Rad Oncol Biol Phys 2007, 68:334-340.
5. Breast cancer quality standard: NICE quality standards (QS12) National Institute for Health and Care Excellence, (accessed Jan 7, 2015). https://www.nice.org.uk/guidance/qs12.
6. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-conserving surgery in women with localized cancer of the breast. N Engl J Med 1993, 328:1587-1591.
7. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995, 333:1456-1461.
8. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 1996, 348:708-713. on behalf of Scottish Cancer Trials Breast Group.
9. Fisher B, Anderson S Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg 1994, 18:63-69.
10. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with breast cancers of one centimetre or less. J Clin Oncol 2002, 20:4141-4149.
11. Mannino M, Yarnold JR Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?. Radiother Oncol 2009, 90:14-22.
12. Altman DG, Andersen PK Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999, 319:1492-1495.
13. Lockyer AP, Ellis IO, Morgan DAL, et al. Factors influencing local recurrence after excision and radiotherapy for a primary breast cancer. Br J Surg 1989, 76:890-894.
14. Winzer KJ, Sauerbrei W, Braun M, et al. Radiation and tamoxifen after breast conserving surgery: updated results of a 2 × 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 2010, 46:95-101.
15. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer 1995, 76:259-267.
16. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-conserving surgery in women with localized cancer of the breast. N Engl J Med 1993, 328:1587-1591.
17. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without radiation in women 70 or older with early breast cancer. N Engl J Med 2004, 351:971-977.
18. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 2013, 31:2382-2387.
19. Tinterri C, Gatzemeier W, Zanini V, et al. Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomized multicentre trial. Breast 2009, 18:373-377.
20. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 2011, 378:1707-1716. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
21. Soulos PR, Yu JB, Roberts KB, et al. Assessing the impact of a cooperative group trial on breast cancer care in the Medicare population. J Clin Oncol 2012, 30:1601-1607.
22. Smith IE, Ross G Breast radiotherapy after lumpectomy: no longer always necessary. N Engl J Med 2004, 351:1021-1023.
23. Carlson RW, McCormick B Update: NCCN breast cancer clinical practice guidelines. J Natl Compr Canc Netw 2005, 3(suppl 1):S7-11.
24. Kaidar-Person O, Kuten A, Walker GA, Morgan DA Should radiotherapy be omitted in women aged 70 years or older with early breast cancer?. J Clin Oncol 2013, 36:4569.
25. Prescott RJ, Kunkler IH, Williams LJ, et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population: the PRIME trial. Health Technol Assess 2007, 11:1-149.
26. Williams LJ, Kunkler IH, King CC, Jack W, van der Pol M A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population: quality of life at 5 years in the PRIME trial. Health Technol Assess 2011, 15:1-57.
27. Smith BD, Buccholz TA Radiation treatments after breast conserving-therapy for elderly patients. J Clin Oncol 2013, 31:2367-2368.
28. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013, 368:987-998.
29. Grantzau T, Mellerkjær L, Overgaard J Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol 2013, 106:42-49.
30. Courdi A, Gerard JP Radiotherapy for elderly patients with breast cancer. J Clin Oncol 2013, 31:4571.
31. Bane AL, Whelan TJ, Pond GR, et al. Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Ann Oncol 2014, 25:992-998.